Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

375.94
+11.363.12%
Pre-market: 378.502.56+0.68%06:36 EDT
Volume:413.32K
Turnover:156.34M
Market Cap:10.47B
PE:-29.23
High:387.99
Open:370.35
Low:365.37
Close:364.58
52wk High:392.70
52wk Low:37.19
Shares:27.85M
Float Shares:24.08M
Volume Ratio:1.02
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:7.81
PE(LYR):-27.90

Loading ...

Movement Alert|Praxis Precision Medicines, Inc. Rises 5.15% in Regular Trading, Trading at $389.76

Market Focus
·
Aug 20

Praxis Precision Medicines Could Be Approaching 'Perfect Trifecta,' Oppenheimer Says

MT Newswires Live
·
Aug 17

Praxis Precision Medicines, Inc. : Raymond James Raises Target Price to $945 from $765

THOMSON REUTERS
·
Aug 17

Praxis Precision Med is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Immunocore Holdings (IMCR) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Aug 07

Praxis Precision price target raised to $514 from $400 at Baird

TIPRANKS
·
Aug 07

Praxis Precision Medicines, Inc. : Deutsche Bank Raises Target Price to $475 from $374

THOMSON REUTERS
·
Aug 07

Definium Therapeutics Q2 Net Loss Widens on Higher Warrant Costs

Reuters
·
Aug 07

Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Privia Health Group (PRVA) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Aug 07

Wedbush Adjusts PT on Praxis Precision Medicines to $188 From $162, Maintains Underperform Rating

MT Newswires Live
·
Aug 06

Movement Alert|Praxis Precision Medicines, Inc. Rises 16.43% in Regular Trading, Q2 Earnings and Pipeline Catalysts Drive Surge

Market Focus
·
Aug 06

Praxis Precision Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Stock Track | Praxis Precision Medicines Soars 14.56% Intraday on Q2 Earnings Beat and Positive FDA Pipeline Updates

Stock Track
·
Aug 06

Praxis Q2 2026 results: $1.4 billion liquidity supports runway into 2028

TradingKey
·
Aug 06

Praxis Precision Medicines Posts Investor Deck Highlighting Late-Stage CNS Pipeline, Upcoming PDUFA Dates

Reuters
·
Aug 06

Stock Track | Praxis Precision Medicines Soars 5.88% in Pre-market on Q2 Earnings Beat and Upbeat Pipeline Progress

Stock Track
·
Aug 06

Praxis Precision Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 06

Praxis Precision Net Loss Widens 17.7% to $83.72 Million in Q2 FY26

Reuters
·
Aug 06

Earnings Flash (PRAX) Praxis Precision Medicines Posts Q2 Loss $2.87 a Share, vs. FactSet Est of $3.64 Loss

MT Newswires Live
·
Aug 06